[{"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM Amneal Pharmaceuticals Gets US FDA Approvals for Alzheimer's, Oncology Treatments, Gastrointestinal Disease MT Newswires Thu, Jan 23, 2025, 5:31 PM 1 min read Amneal Pharmaceuticals (AMRX) said Thursday that the US Food and Drug Administration (FDA) has appro PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AMRX", "date": "2025-01-23T17:31:19", "sentiment": {"score": 0.06832069251686335, "confidence": 0.079836405813694, "probabilities": {"positive": 0.079836405813694, "negative": 0.011515713296830654, "neutral": 0.9086478352546692}}, "embedding": [-0.035081859678030014, -0.12559670209884644, 0.0536331832408905, 0.052330806851387024, 0.16728363931179047, -0.027477575466036797, -0.11604387313127518, 0.11789992451667786, -0.012122642248868942, 0.09128490090370178, -0.033469635993242264, 0.1831318438053131, -0.02490338310599327, 0.08299282193183899, -0.10279299318790436, 0.11683620512485504, 0.17603926360607147, -0.029136449098587036, -0.07459192723035812, 0.06034974008798599, -0.022976301610469818, 0.11630332469940186, 0.14190450310707092, 0.08592068403959274, -0.029391134157776833, -0.005660069640725851, -0.15088386833667755, -0.1765880137681961, 0.05078993737697601, -0.008843471296131611, 0.04314250499010086, -0.09084072709083557, 0.04395661503076553, -0.057039983570575714, -0.0033487339969724417, -0.08976630121469498, -0.04108603298664093, 0.021173594519495964, -0.09683149307966232, 0.025087682530283928, 0.08077360689640045, -0.301439106464386, -0.19056089222431183, 0.1839206963777542, -0.05369431897997856, -0.19550266861915588, -0.11343318969011307, 0.022415459156036377, 0.16046100854873657, 0.17688439786434174, -0.1658271998167038, -0.11541935801506042, 0.020462557673454285, -0.039370160549879074, 0.011437074281275272, -0.001009073806926608, -0.1502387523651123, -0.09995223581790924, 0.015886567533016205, 0.010774222202599049, -0.06643824279308319, -0.13501806557178497, -0.008234916254878044, 0.166004478931427, -0.1257980316877365, 0.14251768589019775, -0.0985245332121849, 0.049750301986932755, -0.03078422322869301, -0.26867082715034485, -0.014337874948978424, 0.014187085442245007, 0.17509733140468597, -0.007239064667373896, 0.04358207806944847, 0.09994962066411972, 0.20129607617855072, 0.04426555708050728, 0.15614546835422516, -0.1116819679737091, 0.0970994085073471, -0.11351994425058365, 0.07061219215393066, -0.1358794867992401, 0.16770879924297333, -0.060027819126844406, -0.08472811430692673, -0.0266874972730875, 0.023607170209288597, -0.03338175639510155, 0.15379762649536133, -0.10961505025625229, 0.014828409999608994, -0.044611796736717224, -0.1303229182958603, -0.03603014349937439, -0.10652828216552734, -0.034347210079431534, -0.18997810781002045, 0.044273752719163895, -0.013705294579267502, -0.04773595556616783, -0.1891356110572815, 0.0021500582806766033, -0.14860571920871735, -0.08535002171993256, -0.06994634121656418, 0.018736300989985466, 0.06142584979534149, 0.2140466570854187, -0.006102388259023428, 0.05106586217880249, 0.10694421082735062, -0.056108929216861725, -0.07616088539361954, 0.14990858733654022, -0.03966737911105156, -0.16709047555923462, 0.22260914742946625, 0.007502243388444185, -0.04978295415639877, -0.08435316383838654, -0.04866994172334671, -0.1040097177028656, 0.11037261039018631, 0.0018644548254087567, -0.014965678565204144, 8.854231199996411e-33, -0.07010089606046677, 0.20901045203208923, 0.03499457612633705, 0.004321773536503315, 0.00918633583933115, 0.0263816025108099, 0.03769643232226372, -0.1271558552980423, -0.10149729251861572, -0.19077561795711517, -0.20959144830703735, 0.2435036152601242, -0.125653937458992, 0.18421386182308197, -0.08374657481908798, -0.21228833496570587, -0.1012636050581932, 0.11393105238676071, 0.17350366711616516, 0.0346381701529026, -0.020004097372293472, -0.11310926079750061, -0.007936924695968628, -0.0162888802587986, -0.040626902133226395, 0.17010346055030823, -0.07313908636569977, -0.04365486279129982, 0.06487972289323807, 0.06732023507356644, -0.11941375583410263, 0.09275827556848526, -0.08919128775596619, 0.015530392527580261, -0.10519321262836456, 0.06634996831417084, -0.11708059161901474, -0.04214536398649216, -0.17080236971378326, -0.06765446811914444, 0.006880328990519047, 0.09488392621278763, -0.1279723048210144, 0.05750426650047302, 0.05512620136141777, -0.03739113733172417, -0.05665939301252365, -0.01615878939628601, 0.06620273739099503, -0.18416312336921692, 0.028857097029685974, 0.08030340075492859, -0.1900186687707901, -0.16798098385334015, -0.0019456148147583008, -0.027307502925395966, -0.15887755155563354, -0.12866860628128052, 0.20043233036994934, 0.023984897881746292, 0.1278071105480194, 0.13419127464294434, 0.00428441958501935, 0.04195232689380646, -0.1840745508670807, 0.126722052693367, -0.12348581850528717, -0.11063998192548752, -0.09599775075912476, 0.14366398751735687, 0.1946328580379486, -0.048666246235370636, 0.08615659922361374, 0.11153783649206161, -0.14098086953163147, 0.11439873278141022, 0.014945276081562042, 0.013452643528580666, 0.15753699839115143, -0.05691651627421379, 0.14402036368846893, -0.08310133218765259, 0.1640714555978775, 0.18055562674999237, 0.04905673488974571, 0.1034182533621788, -0.04267929121851921, 0.03248634934425354, 0.07247573882341385, 0.1057504191994667, -0.02469146065413952, -0.06694325059652328, 0.020614033564925194, 0.15699397027492523, -0.07849658280611038, -1.3515850208801986e-32, -0.1357250064611435, 0.05011799558997154, 0.08244000375270844, -0.10515561699867249, -0.09780155122280121, 0.028930803760886192, -0.061086755245923996, 0.14640125632286072, 0.3405574858188629, -0.07014040648937225, 0.05860692635178566, 0.10724902898073196, 0.01738010346889496, 0.09851749241352081, 0.030604463070631027, -0.04361326992511749, 0.08129895478487015, -0.1387719213962555, -0.16934488713741302, -0.016280226409435272, -0.07747820019721985, 0.18321992456912994, -0.17600488662719727, 0.2085925042629242, -0.0284943338483572, 0.02916303649544716, 0.12542420625686646, 0.06736811250448227, -0.008599117398262024, -0.11683747917413712, -0.1317424178123474, 0.03645231947302818, -0.18055444955825806, 0.047200556844472885, -0.07385250926017761, 0.021898282691836357, 0.0964716225862503, -0.027315286919474602, -0.04759170114994049, -0.09765816479921341, 0.17065267264842987, -0.12675468623638153, -0.1689693182706833, 0.05053136125206947, -0.05930336192250252, -0.015672149136662483, -0.12002450227737427, -0.04963981360197067, 0.11752085387706757, -0.06487646698951721, -0.09951669722795486, 0.023298276588320732, -0.024012047797441483, -0.015328534878790379, -0.13475072383880615, 0.11609530448913574, -0.005619649775326252, -0.13876765966415405, 0.04398246482014656, -0.01040016021579504, -0.0038062522653490305, 0.19458356499671936, -0.11645875871181488, -0.1881919801235199, 0.055751048028469086, 0.03736172989010811, 0.158920019865036, -0.1881028115749359, 0.04547369107604027, 0.03710652142763138, 0.04949495941400528, -0.1144019290804863, -0.18824021518230438, -0.1335132122039795, 0.0942390114068985, 0.11946278810501099, 0.05240426957607269, -0.0026639560237526894, -0.06997080147266388, 0.01985868252813816, 0.07394538819789886, -0.08531031012535095, 0.004765752702951431, -0.06815490871667862, -0.006384155713021755, -0.034474391490221024, 0.1614008992910385, -0.12760810554027557, -0.04910475015640259, -0.023537002503871918, -0.0933520570397377, -0.05793461203575134, -0.29725754261016846, 0.03940083459019661, 0.0381646454334259, -1.0046580456446463e-07, 0.2093268632888794, -0.14307481050491333, 0.04027223959565163, 0.010440860874950886, 0.07876569777727127, -0.009350216947495937, -0.11697517335414886, 0.011134468019008636, -0.022411707788705826, 0.1883498579263687, 0.010256634093821049, 0.14026810228824615, -0.042543813586235046, -0.04292264208197594, 0.0014299482572823763, 0.08588368445634842, -0.015158234164118767, 0.15026047825813293, -0.03838308900594711, -0.09754655510187149, -0.1550077646970749, 0.1907302886247635, 0.13597963750362396, -0.13143542408943176, 0.11840252578258514, -0.11053162813186646, -0.057930056005716324, 0.020541144534945488, 0.10172060132026672, 0.03204980120062828, -0.06951253861188889, 0.045231107622385025, -0.04517264664173126, 0.030681973323225975, -0.02998989261686802, -0.1034303531050682, 0.17246219515800476, 0.039492715150117874, 0.03340359032154083, -0.04095960035920143, 0.043091848492622375, 0.010967808775603771, 0.08780773729085922, 0.06779459118843079, -0.059717461466789246, 0.06804715842008591, -0.15044724941253662, -0.04660830274224281, 0.16326478123664856, 0.06479950994253159, 0.04825868457555771, -0.10186915099620819, 0.21300870180130005, -0.2041655033826828, 0.025817420333623886, -0.0367518775165081, -0.06720080226659775, -0.1240568682551384, -0.005211906507611275, -0.044614408165216446, 0.22878018021583557, -0.24373744428157806, 0.18532264232635498, 0.10579708963632584], "changes": {"1wk": -2.6106751981363843}}, {"text": "LIVE The latest news and updates on Trump's tariffs Corcept Therapeutics Incorporated (CORT) Hit a 52 Week High, Can the Run Continue? Zacks Equity Research Fri, Jan 24, 2025, 5:15 PM 4 min read In This Article: CORT Have you been paying attention to shares of Corcept Therapeutics (CORT) ? Shares have been on the move with the stock up 16.2% over the past month. The stock hit a new 52-week high of $62.98 in the previous session. Corcept Therapeutics has gained 23.6% since the start of the year compared to the -2.1% move for the Zacks Medical sector and the -7.9% return for the Zacks Medical - Drugs industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on October 30, 2024, Corcept reported EPS of $0.41 versus consensus estimate of $0.27 while it beat the consensus revenue estimate by 6.07%. For the current fiscal year, Corcept is expected to post earnings of $1.84 per share on $689.04 million in revenues. Meanwhile, for the next fiscal year, the company is expected to earn $2.84 per share on $777.04 million in revenues. This represents a year-over-year change of 36.44% and 12.77%, respectively. Valuation Metrics Corcept may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level. On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style. Corcept has a Value Score of C. The stock's Growth and Momentum Scores are A and C, respectively, giving the company a VGM Score of B. In terms of its value breakdown, the stock currently trades at 33.8X current fiscal year EPS estimates, which is a premium to the peer industry average of 20.7X. On a trailing cash flow basis, the stock currently trades at 65X versus its peer group's average of 8X. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective. Zacks Rank We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Corcept currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts. Story Continues Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Corcept meets the list of requirements. Thus, it seems as though Corcept shares could still be poised for more gains ahead. How Does CORT Stack Up to the Competition? Shares of CORT have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is AMNEAL PHARMACEUTICALS, INC. (AMRX) . AMRX has a Zacks Rank of # 2 (Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of A. Earnings were strong last quarter. AMNEAL PHARMACEUTICALS, INC. beat our consensus estimate by 23.08%, and for the current fiscal year, AMRX is expected to post earnings of $0.70 per share on revenue of $2.77 billion. Shares of AMNEAL PHARMACEUTICALS, INC. have gained 12.2% over the past month, and currently trade at a forward P/E of 12.59X and a P/CF of 6.52X. The Medical - Drugs industry is in the top 35% of all the industries we have in our universe, so it looks like there are some nice tailwinds for CORT and AMRX, even beyond their own solid fundamental situation. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AMRX", "date": "2025-01-24T17:15:03", "sentiment": {"score": 0.3579567763954401, "confidence": 0.3889170289039612, "probabilities": {"positive": 0.3889170289039612, "negative": 0.03096025250852108, "neutral": 0.5801227688789368}}, "embedding": [-0.03730003535747528, -0.02551475539803505, -0.06472928822040558, -0.03524608910083771, -0.052450865507125854, 0.01246556919068098, -0.004868598654866219, 0.08758778125047684, 0.0695950910449028, 0.03921157866716385, -0.052264854311943054, 0.06687458604574203, -0.08747361600399017, -0.012701278552412987, -0.0947486013174057, -0.03381551802158356, 0.07485669106245041, -0.07076774537563324, -0.0809994637966156, 0.08548443764448166, -0.07919998466968536, -0.05322030186653137, 0.022361550480127335, -0.019907429814338684, 0.07511915266513824, 0.02299536019563675, -0.10806545615196228, 0.008830133825540543, -0.1438674032688141, -0.089039146900177, -0.07082594931125641, 0.10340055823326111, 0.018512887880206108, 0.029412465170025826, -0.1394241452217102, -0.032274190336465836, -0.004348937422037125, 0.061492420732975006, 0.1858500838279724, 0.11642193049192429, -0.004095148295164108, 0.03382670506834984, -0.08112306147813797, 0.04351095110177994, -0.08482206612825394, -0.17199058830738068, -0.04115791618824005, 0.021024249494075775, -0.02553042583167553, 0.06920622289180756, -0.1752820461988449, 0.048376910388469696, -0.025482650846242905, 0.04480307176709175, -0.0595373660326004, 0.06425579637289047, -0.10940242558717728, -0.027087079361081123, 0.09657466411590576, -0.0018342894036322832, 0.00015879841521382332, 0.0371570959687233, 0.09499514102935791, 0.06494934111833572, 0.17960689961910248, -0.05186142027378082, 0.013999974355101585, 0.04316224902868271, -0.017247797921299934, -0.026518333703279495, 0.15325525403022766, -0.0349092036485672, -0.11851757019758224, -0.09645484387874603, -0.06501363962888718, 0.13495703041553497, 0.030942566692829132, 0.016731038689613342, 0.07535626739263535, -0.13517512381076813, 0.09818492829799652, 0.07596947252750397, -0.025282137095928192, -0.027601245790719986, 0.055755674839019775, 0.001795104006305337, 0.04963519424200058, 0.010560201480984688, 0.1121876984834671, 0.028504326939582825, 0.05121808499097824, -0.07723948359489441, -0.018153216689825058, -0.038502223789691925, 0.011043593287467957, 0.10721486061811447, -0.011466202326118946, -0.07058525085449219, -0.03488290682435036, 0.10291898250579834, 0.05955236405134201, 0.088461734354496, -0.0928046926856041, -0.06658254563808441, 0.04045603796839714, -0.13663318753242493, 0.1717435121536255, 0.06955305486917496, 0.07010720670223236, 0.045198146253824234, -0.046179670840501785, 0.10944614559412003, -0.06933225691318512, -0.1030854731798172, -0.022117989137768745, 0.09018342196941376, -0.017145074903964996, 0.11594145745038986, 0.139260932803154, 0.07995109260082245, 0.1691906750202179, 0.09334184229373932, -0.012435704469680786, -0.06332065165042877, -0.026999523863196373, -0.0028718700632452965, -0.1472753882408142, 8.759214522251507e-33, -0.03657048940658569, 0.130378857254982, 0.021761637181043625, -0.017382560297846794, -0.10980678349733353, -0.043378014117479324, -0.009921769611537457, -0.04082886874675751, -0.05316319316625595, -0.1317414939403534, -0.13139407336711884, 0.14381612837314606, -0.05760359764099121, -0.017763637006282806, 0.001383766531944275, -0.10080582648515701, -0.037075553089380264, 0.009528426453471184, 0.023285647854208946, -0.06830102950334549, 0.0624922513961792, 0.03031972050666809, -0.04989195242524147, 0.0747152715921402, 0.001479308120906353, -0.07817162573337555, -0.0778777003288269, 0.055225856602191925, -0.1462896168231964, 0.05009188503026962, 0.012610184960067272, 0.0491684228181839, 0.04827617108821869, -0.04716254025697708, 0.008507953956723213, -0.08927839994430542, -0.04306481033563614, -0.07258465886116028, 0.11856449395418167, -0.02785573899745941, -0.13815385103225708, 0.06497325748205185, -0.11459830403327942, -0.05664265900850296, -0.08303782343864441, 0.010927981697022915, -0.06488750874996185, 0.013848942704498768, -0.0632145032286644, -0.024494873359799385, -0.07733157277107239, 0.05357515811920166, 0.0219822246581316, -0.03712814673781395, -0.09736041724681854, 0.018044007942080498, -0.03783446550369263, -0.15434353053569794, 0.0764380395412445, 0.07369275391101837, 0.057461291551589966, 0.11927101016044617, 0.01107630506157875, -0.010104607790708542, -0.14355576038360596, 0.14834657311439514, -0.03929843008518219, 0.015766408294439316, 0.08160978555679321, 0.13507166504859924, -0.013098293915390968, 0.0258297361433506, 0.03195406496524811, -0.054301224648952484, 0.15192559361457825, 0.00529195461422205, 0.0064270514994859695, -0.05957578495144844, 0.009068315848708153, 0.08891473710536957, 0.05114733427762985, -0.043584294617176056, 0.027464983984827995, -0.01364104077219963, 0.055215027183294296, -0.009943735785782337, 0.008559497073292732, 0.005595502443611622, -0.009092442691326141, -0.033761829137802124, 0.016847707331180573, 0.020122207701206207, 0.031987085938453674, -0.005895265378057957, 0.03647889941930771, -8.495212450052237e-33, -0.0905064195394516, 0.0974361002445221, 0.03062533587217331, -0.021139495074748993, -0.09193029254674911, 0.04494241997599602, 0.020821353420615196, -0.06571268290281296, -0.05451706796884537, -0.0038113705813884735, 0.034859366714954376, 0.03385445475578308, -0.08988113701343536, 0.004019084386527538, -0.04507803916931152, 0.031425703316926956, 0.027782075107097626, -0.03752242773771286, 0.006296453531831503, -0.008529537357389927, 0.057479389011859894, 0.1833173930644989, -0.1339709460735321, 0.10838791728019714, 0.05267595127224922, 0.11188836395740509, -0.06410731375217438, 0.009126119315624237, 0.024051334708929062, -0.03508252277970314, -0.02753475308418274, -0.0323740616440773, -0.09007781744003296, 0.035549312829971313, -0.05581078678369522, -0.0037184692919254303, -0.03903607279062271, -0.13224872946739197, -0.03747306391596794, -0.051926419138908386, 0.12291717529296875, -0.11325104534626007, 0.0715206116437912, -0.01852298527956009, 0.1140880137681961, 0.019763663411140442, 0.06350014358758926, 0.07460014522075653, 0.20900273323059082, 0.10752318799495697, 0.005310213193297386, 0.07731133699417114, -0.1788870096206665, 0.15163055062294006, -0.0807870551943779, 0.055488914251327515, -0.0037780245766043663, -0.07165375351905823, -0.11324269324541092, -0.0118251359090209, 0.048886168748140335, 0.18745456635951996, -0.022050123661756516, 0.029144711792469025, 0.0006528906524181366, -0.034593190997838974, 0.03275366500020027, -0.04792512208223343, 0.03339717537164688, -0.10531370341777802, -0.03975841775536537, -0.03586316108703613, 0.16129592061042786, -0.17123273015022278, -0.03655657172203064, 0.18664151430130005, 0.042630910873413086, -0.10014812648296356, -0.0859416127204895, 0.03073170967400074, -0.03874926269054413, 0.0004928838461637497, 0.08515308797359467, 0.0115508446469903, -0.11277909576892853, 0.12607815861701965, 0.02058250643312931, -0.028610821813344955, -0.06693200021982193, 0.03459459915757179, -0.0800015851855278, -0.15827473998069763, -0.08511091023683548, -0.0721060186624527, 0.023329809308052063, -1.0009453887960262e-07, 0.022605841979384422, -0.02806823141872883, 0.021581947803497314, -0.034978851675987244, 0.07234843075275421, 0.03981626033782959, -0.01818503998219967, -0.09784089028835297, 0.08918222784996033, 0.09709697961807251, 0.114021897315979, 0.04324030131101608, -0.1521391123533249, 0.06774671375751495, -0.1526080220937729, -0.03989787399768829, -0.10374437272548676, 0.11122316122055054, -0.05633131042122841, -0.16086262464523315, -0.05246464163064957, 7.146969437599182e-06, 0.10352285951375961, 0.0037862714380025864, -0.019806528463959694, -0.0072202738374471664, -0.08968976140022278, 0.020487699657678604, 0.01106959953904152, 0.062380142509937286, 0.050020672380924225, 0.005568505264818668, 0.04941943287849426, 0.011712444946169853, -0.01372360810637474, -0.04466435685753822, 0.04234236851334572, 0.08231784403324127, 0.021455802023410797, 0.11707562208175659, -9.350990876555443e-05, 0.030757756903767586, 0.009066316299140453, 0.0605667382478714, 0.01194850355386734, -0.12345130741596222, -0.0384124293923378, 0.057528555393218994, 0.04375920444726944, -0.14816217124462128, 0.09809060394763947, -0.07395389676094055, 0.0052717989310622215, 0.004943379200994968, 0.0864391177892685, 0.013540626503527164, -0.07684236764907837, -0.05778885632753372, -0.22422587871551514, -0.06056569144129753, 0.05886491760611534, -0.23483359813690186, 0.05662708729505539, 0.10162165760993958], "changes": {"1wk": -1.1520780870260745}}, {"text": "LIVE The latest news and updates on Trump's tariffs Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin Business Wire Thu, Jan 23, 2025, 4:00 PM 4 min read In This Article: AMRX Approval of three important therapies for dementia, oncology and gastrointestinal disease Granted 180-day exclusivity for memantine/donepezil extended-release capsules Tentative approval of rifaximin, a product for treating IBS-D BRIDGEWATER, N.J., January 23, 2025 --( BUSINESS WIRE )--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (\"Amneal\" or the \"Company\") today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references Abbvie\u2019s NAMZARIC \u00ae , and Everolimus 2 mg, 3 mg and 5 mg extended-release capsules, which references Novartis\u2019 AFINITOR DISPERZ \u00ae . In addition, the FDA has granted tentative approval to Amneal\u2019s rifaximin 550 mg oral tablets, which references Bausch Health\u2019s XIFAXAN \u00ae . The FDA approval was tentative as this product is involved in litigation. Memantine/donepezil extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer\u2019s type. The product has launched with 180-day exclusivity. Everolimus tablets for oral suspension are indicated for the treatment of Tuberous Sclerosis Complex (TSC)-Associated Subependymal Giant Cell Astrocytoma (SEGA) in adult and pediatric patients aged one year or older. This launch increases the supply of an oncology product that has limited suppliers. Rifaximin 550 mg oral tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. \"Amneal\u2019s competitive advantage in the Affordable Medicines business remains our core capabilities to drive innovation at scale across complex categories to expand the breadth and depth of our portfolio,\" said Andy Boyer, Executive Vice President, Chief Commercial Officer, Affordable Medicines. \"With our 180-day exclusivity on memantine/donepezil, increasing supply for everolimus, and the tentative approval of rifaximin, we are continuing to expand our differentiated portfolio and providing new key therapies for our customers, providers and patients.\" The most common adverse reactions with memantine hydrochloride were headache, diarrhea, and dizziness. The most common adverse reactions occurring in patients receiving donepezil include diarrhea, anorexia, vomiting, nausea, and bruising. For complete prescribing information, see package insert available here . The most common adverse reactions with everolimus tablets in patients treated for TSC-Associated SEGA: are stomatitis and respiratory tract infection. For complete prescribing information, see package insert available here . Continua a leggere According to IQVIA \u00ae , U.S. annual sales for memantine/donepezil tablets, everolimus tablets and rifaximin tablets for the 12 months ended November 2024 were approximately $88 million, $114 million, and $2.6 billion (for all approved indications of XIFAXAN \u00ae ), respectively. About Amneal Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com . Forward-Looking Statements Certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). Such forward-looking statements include statements regarding management\u2019s intentions, plans, beliefs, expectations, financial results, or forecasts for the future, including among other things: discussions of future operations; expected or estimated operating results and financial performance; and statements regarding our positioning, including our ability to drive sustainable long-term growth, and other non-historical statements. Words such as \"plans,\" \"expects,\" \"will,\" \"anticipates,\" \"estimates,\" and similar words, or the negatives thereof, are intended to identify estimates and forward-looking statements. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company\u2019s filings with the Securities and Exchange Commission, including under Item 1A, \"Risk Factors\" in the Company\u2019s most recent Annual Report on Form 10-K and in its subsequent reports on Forms 10-Q and 8-K. Forward-looking statements included herein speak only as of the date hereof and we undertake no obligation to revise or update such statements to reflect the occurrence of events or circumstances after the date hereof. View source version on businesswire.com: https://www.businesswire.com/news/home/20250123740756/en/ Contacts Investor Contact Anthony DiMeo VP, Investor Relations anthony.dimeo@amneal.com Visualizza commenti Condizioni e Informativa sulla privacy Privacy Dashboard Storie consigliate", "symbol": "AMRX", "date": "2025-01-23T16:00:00", "sentiment": {"score": 0.3708890909329057, "confidence": 0.3813903033733368, "probabilities": {"positive": 0.3813903033733368, "negative": 0.010501212440431118, "neutral": 0.6081085205078125}}, "embedding": [-0.09538277238607407, -0.08547816425561905, -0.08659549057483673, -0.051029104739427567, -0.14199033379554749, -0.10842902958393097, -0.0575663223862648, 0.2606712579727173, 0.09878912568092346, -0.002177824731916189, -0.049396220594644547, 0.12041936814785004, 0.0767882913351059, 0.1100814938545227, -0.13001219928264618, 0.07421256601810455, 0.16148066520690918, 0.13248573243618011, -0.10603023320436478, 0.08269019424915314, 0.1296178698539734, 0.0983387678861618, 0.14084023237228394, 0.11338264495134354, -0.07100868225097656, 0.09072749316692352, -0.09716034680604935, 0.025584165006875992, 0.08487188071012497, -0.03513329476118088, 0.06836812198162079, 0.11225564032793045, -0.01076086238026619, -0.1912735104560852, -0.0037390622310340405, 0.010569414123892784, -0.160879984498024, 0.08768504858016968, -0.09071566164493561, -0.03799183666706085, -0.015312692150473595, -0.10860016196966171, -0.07406234741210938, 0.0337989404797554, -0.0685720145702362, -0.22929197549819946, -0.11830276250839233, 0.03320874273777008, 0.07305292785167694, 0.27076455950737, -0.13317815959453583, -0.06548696756362915, -0.038063809275627136, 0.18667417764663696, -0.08076288551092148, -0.039507344365119934, -0.18671798706054688, 0.013742915354669094, -0.034057870507240295, 0.10374274849891663, -0.10908471047878265, -0.12447387725114822, 0.05936770141124725, -0.012239431962370872, -0.02942446433007717, 0.1980060487985611, -0.1226791962981224, -0.11235521733760834, 0.09096099436283112, -0.13859710097312927, 0.04435519874095917, -0.16086143255233765, 0.02132290229201317, 0.20028361678123474, -0.02842028997838497, -0.0015577632002532482, 0.21338272094726562, 0.14081121981143951, 0.0776849091053009, -0.04184827208518982, 0.04733375087380409, 0.0006718095391988754, 0.10978017002344131, -0.07427680492401123, 0.1444110870361328, 0.04793592914938927, -0.05247587710618973, 0.23457248508930206, 0.09411533176898956, 0.017209850251674652, 0.1690986156463623, 0.022430825978517532, -0.015005533583462238, -0.05950697883963585, -0.0012374557554721832, -0.14938336610794067, -0.11302778124809265, 0.037343982607126236, -0.057687196880578995, -0.023227229714393616, 0.06977766007184982, -0.002931614639237523, -0.17147481441497803, -0.04688388109207153, 0.027613705024123192, -0.06143033504486084, 0.11209622025489807, -0.09302262961864471, 0.016282938420772552, -0.01095675490796566, -0.07584132254123688, -0.004555638879537582, 0.02228436805307865, 0.01442958228290081, -0.1544717699289322, 0.15587201714515686, -0.012272726744413376, 0.027083151042461395, 0.24356913566589355, -0.07810664176940918, -0.046439170837402344, -0.010026183910667896, 0.09017404913902283, -0.1207134872674942, 0.11797453463077545, 0.07541382312774658, -0.06733083724975586, 9.187090792530973e-33, -0.18139876425266266, 0.07758615911006927, -0.08184485137462616, 0.16085344552993774, -0.04294276237487793, 0.00931021012365818, 0.033786591142416, 0.0666799545288086, -0.09253564476966858, -0.15767505764961243, -0.16454076766967773, 0.12172666937112808, -0.08356428146362305, 0.16952410340309143, -0.004481341689825058, -0.13989096879959106, 0.0027484968304634094, -0.05469324812293053, 0.060204338282346725, -0.04506979510188103, -0.0020274585112929344, 0.04627501964569092, -0.015275664627552032, 0.07677443325519562, -0.04767948389053345, 0.08051398396492004, -0.11469003558158875, 0.1440342664718628, 0.0905550941824913, 0.020084433257579803, 0.013141458854079247, -0.05511751025915146, -0.04490583389997482, -0.14434266090393066, -0.2155563235282898, -0.0053624436259269714, -0.192112535238266, -0.07538757473230362, -0.07016672194004059, 0.021957453340291977, -0.021772131323814392, 0.19304469227790833, -0.23433029651641846, -0.004638496786355972, 0.045484334230422974, -0.09170766919851303, -0.10748112201690674, 0.0613226592540741, 0.05068005621433258, -0.08322098851203918, 0.12548890709877014, 0.031229082494974136, -0.07232488691806793, -0.07845322787761688, -0.13852183520793915, 0.04820016771554947, -0.10621969401836395, 0.03926205262541771, 0.1475907266139984, 0.12144613265991211, -0.021057412028312683, 0.09329158067703247, -0.014038939028978348, 0.1371753066778183, 0.025382256135344505, 0.1530739665031433, -0.0534183569252491, 0.004894640296697617, -0.1266251504421234, -0.027467157691717148, 0.03682975098490715, -0.059045009315013885, 0.1808536946773529, 0.09142479300498962, 0.0625329539179802, -0.13793069124221802, 0.08152732253074646, 0.07806584239006042, 0.08539263159036636, -0.15083523094654083, 0.09497644007205963, -0.005140887573361397, -0.06320372223854065, 0.1517208367586136, -0.03566492348909378, 0.056017376482486725, -0.002880839630961418, 0.010798316448926926, -0.023323263972997665, 0.024218784645199776, 0.03498111665248871, -0.08813793957233429, -0.04279349744319916, 0.2458990216255188, -0.08178731054067612, -8.094706096363729e-33, -0.04050324857234955, 0.016888733953237534, 0.010649550706148148, 0.020925119519233704, 0.0199696347117424, 0.13282246887683868, 0.12912419438362122, -0.04096464067697525, 0.17139749228954315, -0.1707887500524521, 0.10372133553028107, 0.07064978033304214, -0.0531550794839859, -0.011306148022413254, -0.012895363382995129, 0.06857531517744064, -0.012265468947589397, -0.08267426490783691, -0.14160147309303284, 0.014980370178818703, -0.0010445518419146538, 0.2370995581150055, -0.06002946197986603, 0.02470027655363083, -0.067423515021801, 0.0921732634305954, 0.17099131643772125, -0.07811059802770615, 0.06759051233530045, 0.11888311058282852, -0.04396366700530052, 0.040812164545059204, -0.22754159569740295, -0.018357928842306137, -0.00013328855857253075, -0.04540261626243591, -0.022525839507579803, -0.10947228968143463, -0.13177844882011414, -0.1650950163602829, -0.005983805283904076, 0.08778448402881622, -0.14532949030399323, 0.05512375757098198, 0.027110910043120384, -0.0024569816887378693, 0.005433144047856331, -0.1745128333568573, -0.036272745579481125, 0.0614544041454792, -0.13796654343605042, -0.05155569314956665, 0.05911926552653313, -0.0011432375758886337, -0.05258934199810028, -0.05006435513496399, -0.017347484827041626, -0.23389075696468353, -0.04567687213420868, -0.09461941570043564, -0.026989474892616272, 0.06791996955871582, 0.009276166558265686, -0.1431068331003189, 0.19719642400741577, 0.13189275562763214, 0.05840602517127991, -0.054159119725227356, 0.004781427793204784, -0.08504270017147064, 0.038256727159023285, -0.12429387867450714, 0.01891721785068512, -0.03818589448928833, 0.0942358449101448, 0.2045849859714508, 0.04461706802248955, -0.15730832517147064, -0.08451124280691147, -0.14906303584575653, -0.11911255121231079, -0.05079996958374977, -0.05863373726606369, 0.01846383512020111, -0.08182328194379807, -0.017344046384096146, 0.030539704486727715, 0.046029072254896164, 0.08166497945785522, 0.062201712280511856, 0.12601107358932495, -0.0718977302312851, -0.10497625172138214, 0.1105576902627945, 0.18280929327011108, -9.981853565932397e-08, 0.11470691114664078, -0.1446036696434021, -0.03361531347036362, 0.022092929109930992, 0.057535137981176376, -0.07764890044927597, -0.1266508251428604, 0.04816136881709099, -0.06904131919145584, 0.18186870217323303, 0.14188358187675476, 0.23652637004852295, -0.11371034383773804, -0.02287115715444088, -0.20334285497665405, 0.07338593155145645, -0.011216353625059128, 0.03415441885590553, -0.019539665430784225, -0.00052232900634408, -0.25385409593582153, 0.046249374747276306, 0.19429725408554077, -0.14233097434043884, 0.09287270158529282, -0.09919905662536621, -0.020407676696777344, 0.10876500606536865, 0.0026158937253057957, -0.07219119369983673, -0.05087732896208763, -0.0014782026410102844, 0.10460785031318665, 0.08091731369495392, -0.09846040606498718, -0.14994752407073975, 0.11847347021102905, 0.18193432688713074, 0.08373743295669556, 0.08218692243099213, 0.1197793185710907, -0.16432327032089233, 0.09461286664009094, 0.046706072986125946, 0.0010251794010400772, 0.07232531905174255, -0.19535726308822632, 0.031075360253453255, -0.011747010983526707, 0.07077253609895706, -0.044014640152454376, -0.007382587529718876, 0.10051919519901276, -0.13391967117786407, -0.08865125477313995, 0.06238890439271927, -0.12705835700035095, 0.005996945314109325, 0.06932887434959412, -0.1500786542892456, 0.1182338297367096, -0.06369122862815857, 0.15134796500205994, -0.0421893484890461], "changes": {"1wk": -0.9080689395001383}}, {"text": "LIVE The latest news and updates on Trump's tariffs Amneal (AMRX) Upgraded to Strong Buy: Here's Why Zacks Equity Research Wed, Jan 8, 2025, 8:00 PM 3 min read Amneal Pharmaceuticals (AMRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time. As such, the Zacks rating upgrade for Amneal is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. Most Powerful Force Impacting Stock Prices The change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock. Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Amneal imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher. Harnessing the Power of Earnings Estimate Revisions Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions. The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>. Story Continues Earnings Estimate Revisions for Amneal This pharmaceutical company is expected to earn $0.61 per share for the fiscal year ending December 2024, which represents a year-over-year change of -4.7%. Analysts have been steadily raising their estimates for Amneal. Over the past three months, the Zacks Consensus Estimate for the company has increased 8.1%. Bottom Line Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of 'buy' and 'sell' ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a 'Strong Buy' rating and the next 15% get a 'Buy' rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term. You can learn more about the Zacks Rank here >>> The upgrade of Amneal to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMNEAL PHARMACEUTICALS, INC. (AMRX) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AMRX", "date": "2025-01-08T20:00:13", "sentiment": {"score": 0.14414352178573608, "confidence": 0.1700349897146225, "probabilities": {"positive": 0.1700349897146225, "negative": 0.025891467928886414, "neutral": 0.8040735125541687}}, "embedding": [-0.12439485639333725, -0.03873680531978607, 0.039841681718826294, 0.10220150649547577, 0.076970674097538, 0.010810181498527527, -0.10383689403533936, 0.03979350998997688, 0.18889328837394714, 0.0872432142496109, -0.11556084454059601, 0.14236527681350708, 0.05311352759599686, 0.06551802158355713, -0.14624954760074615, 0.03349681943655014, 0.156453937292099, 0.022945422679185867, -0.1821938157081604, 0.038661010563373566, -0.024172954261302948, -0.06383944302797318, 0.10846711695194244, 0.007868491113185883, 0.05793051794171333, -0.06737876683473587, -0.06061764061450958, 0.08338785916566849, -0.09358250349760056, -0.10050062835216522, -0.08140018582344055, 0.08857069164514542, 0.09324043244123459, -0.026855211704969406, -0.16998519003391266, -0.04705355316400528, 0.04728621616959572, 0.08532113581895828, 0.138545960187912, 0.047037139534950256, -0.03331278637051582, 0.029516903683543205, -0.0992252454161644, -0.020383749157190323, -0.082926444709301, -0.159193754196167, 0.03727337345480919, -0.02595917321741581, -0.03417612984776497, 0.013346454128623009, -0.19844713807106018, -0.06348839402198792, -0.01066309679299593, -0.09004820883274078, -0.09590588510036469, 0.09199844300746918, -0.026514627039432526, -0.011752811260521412, 0.12802761793136597, 0.07530805468559265, 0.013153105974197388, 0.02505444549024105, 0.03927754610776901, 0.042099785059690475, 0.15081048011779785, -0.00882040336728096, -0.054273515939712524, 0.06399516761302948, -0.09159678965806961, -0.025685202330350876, 0.07601213455200195, 0.0020899437367916107, -0.0481758788228035, -0.10942607372999191, -0.03923862427473068, 0.015282176434993744, 0.04187050461769104, 0.061904553323984146, 0.12497922778129578, -0.049526914954185486, -0.0236220620572567, -0.09963635355234146, 0.0021436214447021484, -0.12780070304870605, 0.1381818801164627, -0.05114011839032173, 0.04443616047501564, -0.05263343080878258, 0.054053355008363724, 0.09270432591438293, 0.03139564394950867, -0.1510787010192871, -0.050307631492614746, -0.04447770491242409, 0.08226215839385986, 0.018650107085704803, -0.08628978580236435, 0.0019556982442736626, -0.02879359759390354, 0.06742102652788162, 0.07750656455755234, 0.01592710055410862, -0.10019993036985397, 0.016491563990712166, -0.007138684391975403, -0.13397696614265442, 0.09734229743480682, -0.038675084710121155, 0.03456960618495941, 0.014868888072669506, -0.023113533854484558, 0.05449575185775757, -0.05095803365111351, -0.07329148054122925, -0.06828833371400833, 0.014634501188993454, -0.01115077082067728, 0.03360436111688614, 0.12411709129810333, 0.06789572536945343, 0.14815634489059448, -0.005846177227795124, 0.03685703128576279, -0.056394752115011215, 0.05275452882051468, 0.08463937044143677, -0.08421088755130768, 1.022768981975671e-32, -0.028457103297114372, 0.17005765438079834, -0.020219750702381134, 0.04280984029173851, -0.056777238845825195, -0.055143803358078, 0.013105055317282677, -0.05724143236875534, -0.005552629940211773, -0.1130886822938919, -0.10675795376300812, 0.24024495482444763, -0.048790641129016876, 0.033319707959890366, 0.07399207353591919, -0.0816509872674942, -0.019742652773857117, 0.03040425293147564, 0.021717853844165802, -0.019942978397011757, 0.032329753041267395, -0.025912579149007797, -0.011413145810365677, -0.11854641884565353, -0.02011079713702202, -0.05271396040916443, -0.046017639338970184, 0.05353135988116264, -0.20321454107761383, 0.0259227454662323, 0.036212258040905, 0.08203253895044327, -0.06699471175670624, -0.04741488769650459, -0.1001335084438324, -0.049805883318185806, -0.03826567903161049, -0.09217949211597443, 0.08343645930290222, -0.01927178166806698, -0.048047564923763275, 0.07999199628829956, -0.2316741645336151, -0.04581677168607712, 0.006705489940941334, 0.08886699378490448, -0.1710895597934723, 0.04799014329910278, -0.08454260230064392, -0.0805179625749588, 0.006566453725099564, 0.033205218613147736, -0.009964479133486748, -0.11010752618312836, -0.10885490477085114, 0.013880640268325806, 0.010116838850080967, -0.19260908663272858, 0.030547019094228745, 0.09199843555688858, -0.019331464543938637, 0.16524291038513184, 0.007934273220598698, 0.01756865717470646, -0.1323346048593521, 0.18858346343040466, 0.005749689880758524, 0.13504767417907715, -0.019123442471027374, 0.16745798289775848, -0.006819457747042179, 0.05836229771375656, 0.12063479423522949, -0.07370748370885849, 0.04971431940793991, -0.022402223199605942, -0.14726781845092773, 0.07165545225143433, 0.1215982437133789, -0.038865916430950165, 0.04894249141216278, -0.03408842906355858, 0.10711595416069031, -0.05143587663769722, 0.022681711241602898, 0.0035746158100664616, 0.0174928717315197, 0.015976466238498688, 0.05607950687408447, 0.00915466621518135, 0.10216633975505829, -0.10243427008390427, -0.06121297553181648, 0.12705165147781372, 0.022332580760121346, -1.0418284473799036e-32, -0.17501398921012878, 0.02568887732923031, 0.0036213332787156105, 0.016833536326885223, -0.10205413401126862, -0.02769424393773079, 0.01596609503030777, -0.0017683133482933044, 0.01731446012854576, -0.16500398516654968, -0.047678280621767044, -0.007363550364971161, -0.07714670896530151, 0.05963899940252304, 0.04075580835342407, -0.049596596509218216, -0.03112298808991909, -0.09424714744091034, -0.029781239107251167, -0.06605730205774307, 0.05780494213104248, 0.19488883018493652, -0.08791536092758179, 0.1292877197265625, -0.011570272967219353, 0.00412222184240818, -0.016692616045475006, 0.10011731833219528, 0.08068498969078064, -0.04854344576597214, 0.006711618043482304, 0.022989172488451004, -0.12476679682731628, 0.06435874104499817, -0.023249678313732147, 0.05825142562389374, 0.02325633354485035, -0.15931683778762817, -0.059299178421497345, 0.061643943190574646, 0.13313166797161102, 0.006144901737570763, 0.02373870089650154, -0.039829738438129425, 0.01457214169204235, 0.04409702867269516, 0.02639521099627018, -0.0037588553968816996, 0.12144627422094345, -0.08145716041326523, 0.02113777957856655, 0.023931635543704033, -0.03893116116523743, 0.16209816932678223, -0.16668318212032318, 0.03964291885495186, -0.0491737499833107, -0.020444931462407112, -0.0009800175903365016, 0.07022007554769516, -0.023974372074007988, 0.1551920473575592, 0.04883197322487831, 0.022053061053156853, -0.006645482033491135, -0.040960222482681274, 0.015714891254901886, -0.1595838963985443, 0.06066484749317169, 0.026663895696401596, 0.033486638218164444, -0.13481368124485016, 0.10089830309152603, -0.030661268159747124, -0.01627465710043907, 0.10171429067850113, 0.002808726392686367, -0.119315505027771, -0.1763285994529724, -0.04409855976700783, -0.02737939916551113, 0.04128295183181763, 0.028330599889159203, -0.10874246060848236, -0.061228275299072266, 0.04486123472452164, 0.0724525973200798, 0.06155756860971451, 0.01438029296696186, -0.13826055824756622, -0.031209256500005722, -0.1378263533115387, -0.1914164125919342, -0.07549703121185303, -0.01668528839945793, -9.995628147407842e-08, -0.011540314182639122, -0.0624818429350853, 0.0057221464812755585, 0.049068085849285126, 0.08581741154193878, -0.02052943781018257, 0.007201355881989002, -0.01354617066681385, 0.10862942039966583, 0.11124350130558014, 0.17927351593971252, 0.07393841445446014, -0.12636885046958923, -0.023845622316002846, -0.11029820889234543, 0.03520994633436203, -0.03944350406527519, 0.0845101848244667, 0.02949373610317707, -0.09776192158460617, -0.042854614555835724, 0.08937826752662659, 0.10268597304821014, -0.07481952011585236, 0.16791018843650818, -0.08223644644021988, -0.13739626109600067, 0.016480738297104836, 0.03533318638801575, 0.07525544613599777, 0.07640708237886429, 0.0038515422493219376, 0.11255236715078354, 0.09298451244831085, 0.04929551109671593, 0.043797895312309265, 0.14622759819030762, 0.07253370434045792, 0.013191858306527138, 0.1040775328874588, 0.016968058422207832, -0.008113967254757881, -0.06779865175485611, 0.06142545863986015, -0.026493217796087265, -0.04882454499602318, -0.149135023355484, 0.022675771266222, 0.04641479253768921, -0.08987671881914139, 0.09657960385084152, -0.08207471668720245, 0.03003031387925148, -0.02607664465904236, 0.037485022097826004, -0.02926604077219963, -0.12031427025794983, -0.007432128302752972, -0.11423763632774353, 0.01875614933669567, 0.16800418496131897, -0.14439743757247925, 0.04911695793271065, 0.07396712154150009], "changes": {"1wk": 1.9851096660329741}}, {"text": "LIVE The latest news and updates on Trump's tariffs Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year? Zacks Equity Research Thu, Jan 16, 2025, 5:40 PM 2 min read In This Article: AVAH Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Amneal Pharmaceuticals (AMRX) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. Amneal Pharmaceuticals is a member of our Medical group, which includes 1010 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Amneal Pharmaceuticals is currently sporting a Zacks Rank of #1 (Strong Buy). Over the past 90 days, the Zacks Consensus Estimate for AMRX's full-year earnings has moved 8.7% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive. According to our latest data, AMRX has moved about 3.8% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -4.2% on a year-to-date basis. As we can see, Amneal Pharmaceuticals is performing better than its sector in the calendar year. Another stock in the Medical sector, Aveanna Healthcare (AVAH), has outperformed the sector so far this year. The stock's year-to-date return is 2.2%. Over the past three months, Aveanna Healthcare's consensus EPS estimate for the current year has increased 37.5%. The stock currently has a Zacks Rank #1 (Strong Buy). Breaking things down more, Amneal Pharmaceuticals is a member of the Medical - Drugs industry, which includes 161 individual companies and currently sits at #64 in the Zacks Industry Rank. Stocks in this group have lost about 11.4% so far this year, so AMRX is performing better this group in terms of year-to-date returns. On the other hand, Aveanna Healthcare belongs to the Medical - Outpatient and Home Healthcare industry. This 18-stock industry is currently ranked #86. The industry has moved +11.8% year to date. Investors with an interest in Medical stocks should continue to track Amneal Pharmaceuticals and Aveanna Healthcare. These stocks will be looking to continue their solid performance. Story Continues Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMNEAL PHARMACEUTICALS, INC. (AMRX) : Free Stock Analysis Report Aveanna Healthcare Holdings Inc. (AVAH) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AMRX", "date": "2025-01-16T17:40:09", "sentiment": {"score": 0.9285764759406447, "confidence": 0.9439225792884827, "probabilities": {"positive": 0.9439225792884827, "negative": 0.015346103347837925, "neutral": 0.040731318295001984}}, "embedding": [-0.03164125978946686, -0.1002500057220459, 0.025518957525491714, 0.029642632231116295, -0.009963921271264553, -0.023486625403165817, -0.07399480044841766, 0.1700601577758789, 0.16372990608215332, 0.057440999895334244, -0.1700010448694229, 0.18221937119960785, 0.042593710124492645, 0.062417637556791306, -0.15536493062973022, 0.025327926501631737, 0.12245731800794601, -0.06637561321258545, -0.1355677992105484, 0.0878889262676239, -0.05873860791325569, -0.0786161795258522, 0.09351024031639099, 0.0159288439899683, 0.053940776735544205, 0.027212616056203842, -0.07907119393348694, 0.03007117286324501, -0.06844493001699448, -0.08123601973056793, -0.00507236598059535, 0.09679950773715973, 0.12562121450901031, -0.04694429039955139, -0.1485629379749298, 0.05341086536645889, -0.039010629057884216, 0.07604779303073883, 0.08856676518917084, 0.05721992626786232, -0.03328632935881615, -0.022015031427145004, -0.056438956409692764, -0.06159130111336708, -0.02352137304842472, -0.18390139937400818, -0.01582767814397812, -0.0280294306576252, 0.12544891238212585, 0.06838644295930862, -0.1980571150779724, -0.05630087852478027, -0.053063277155160904, 0.07927650958299637, -0.08127754926681519, 0.08551298081874847, -0.15163834393024445, -0.11427146196365356, 0.03212863206863403, 0.03147059679031372, 0.10282053053379059, 0.06729166209697723, 0.1025499776005745, 0.05568665266036987, 0.030221987515687943, 0.010717490687966347, -0.056839123368263245, 0.03009502775967121, -0.08259470760822296, -0.019036658108234406, 0.11551883816719055, -0.07195482403039932, -0.014010146260261536, -0.003991232253611088, -0.06219736859202385, 0.065279021859169, 0.116116464138031, 0.07243171334266663, 0.154680535197258, -0.04327165335416794, 0.06750674545764923, -0.07125629484653473, -0.06545091420412064, -0.08618922531604767, 0.03542618826031685, -0.008640583604574203, 0.055594854056835175, 0.020361654460430145, 0.057472776621580124, -9.43915219977498e-05, 0.07212857902050018, -0.032195430248975754, -0.0032928800210356712, -0.0371524952352047, 0.1285337656736374, 0.0266694538295269, -0.02275475673377514, -0.014430242590606213, -0.08117173612117767, 0.07937367260456085, 0.09039397537708282, 0.043367475271224976, -0.11931350827217102, -0.06209782138466835, -0.12055131793022156, -0.15766654908657074, 0.09368212521076202, -0.04959392175078392, 0.05741690844297409, 0.06577327102422714, -0.08546698093414307, 0.1155095100402832, -0.09698577970266342, -0.016357790678739548, -0.10658778250217438, 0.07459904998540878, 0.018250035122036934, 0.026741620153188705, 0.15771646797657013, 0.0835745632648468, 0.0404200479388237, 0.01240799855440855, 0.025582080706954002, -0.03704032674431801, 0.17765922844409943, 0.05635276809334755, -0.11891081929206848, 6.709157517205222e-33, -0.0413171723484993, 0.16590651869773865, 0.038826778531074524, -0.0033000241965055466, -0.06245429813861847, 0.009312739595770836, 0.07319027185440063, -0.07585927098989487, -0.06962694972753525, -0.1380642205476761, -0.2899787724018097, 0.10528308153152466, -0.062260888516902924, -0.026021193712949753, 0.058060549199581146, -0.13439932465553284, -0.040736958384513855, -0.013414446264505386, -0.045290108770132065, -0.08845862001180649, -0.017707329243421555, 0.044866740703582764, -0.08081357181072235, 0.01227710023522377, -0.03169021010398865, -0.07311764359474182, -0.09547220170497894, 0.024312013760209084, -0.16205370426177979, 0.006580342072993517, 0.018643617630004883, 0.08266010880470276, -0.07615016400814056, -0.04905478656291962, -0.11001749336719513, -0.03090646117925644, -0.1008792594075203, 0.00717117078602314, 0.1200149655342102, -0.06414719671010971, -0.1483038365840912, 0.1444724202156067, -0.14035366475582123, -0.09892107546329498, 0.06023425608873367, 0.08703870326280594, -0.17580646276474, -0.008918262086808681, -0.06904446333646774, -0.06864023208618164, -0.03874289244413376, 0.013597030192613602, -0.004416767507791519, -0.07383967190980911, -0.038958072662353516, 0.026584558188915253, -0.07971135526895523, -0.06972727924585342, 0.05473054200410843, 0.2334941327571869, 0.04229648783802986, 0.14745230972766876, 0.03730836510658264, 0.0159328393638134, -0.14284458756446838, 0.12785553932189941, 0.0511784553527832, 0.049924395978450775, -0.013614670373499393, 0.21575281023979187, 0.03943215310573578, 0.0059850942343473434, 0.15496279299259186, -0.043303631246089935, 0.08090382814407349, -0.0004439286421984434, -0.0668686106801033, 0.040545959025621414, 0.03728581592440605, -0.013774985447525978, 0.05541183426976204, -0.023612521588802338, 0.029772449284791946, 0.0618252232670784, -0.02534583956003189, -0.0731324702501297, 0.048177771270275116, -0.03990822285413742, 0.0483061745762825, 0.09311971068382263, -0.022535856813192368, -0.07495255768299103, -0.04592188447713852, 0.15611407160758972, -0.0025690714828670025, -7.388590313244628e-33, -0.018178001046180725, 0.059959832578897476, 0.10691490769386292, -0.012337040156126022, -0.09453226625919342, 0.04515499621629715, 0.1356605738401413, 0.0805705338716507, 0.015779059380292892, -0.08988328278064728, 0.053091321140527725, 0.10259738564491272, -0.017436828464269638, 0.0697016566991806, -0.018265392631292343, 0.023312656208872795, 0.05300940200686455, -0.12244728952646255, -0.011964434757828712, -0.07464182376861572, -0.006284636445343494, 0.18809381127357483, -0.16522027552127838, 0.1416681706905365, 0.0019190055318176746, 0.08882357180118561, -0.04481968656182289, 0.09245447814464569, 0.015244545415043831, -0.10924914479255676, -0.04914100468158722, 0.015873020514845848, -0.09147118031978607, 0.0200920682400465, -0.028723876923322678, 0.07258595526218414, -0.050588458776474, -0.16432859003543854, -0.03408210724592209, -0.03548312932252884, 0.19630613923072815, -0.0346834696829319, 0.003447013907134533, 0.010076400823891163, 0.045379623770713806, 0.0010159341618418694, -0.0018590250983834267, -0.0032362875062972307, 0.18357126414775848, -0.06382015347480774, -0.06960852444171906, -0.01477002166211605, -0.05875539034605026, 0.13636469841003418, -0.07404910773038864, 0.07666289061307907, -0.10997209697961807, -0.07264415919780731, -0.15721718966960907, -0.027659017592668533, 0.022310961037874222, 0.1048179641366005, 0.01433511171489954, -0.003976391162723303, -0.0735793486237526, -0.01629370078444481, 0.07976531237363815, -0.1305246204137802, 0.026874158531427383, -0.08900125324726105, 0.00044303853064775467, -0.11401429027318954, 0.041036080569028854, -0.027855444699525833, 0.015311350114643574, 0.12194469571113586, -0.012914707884192467, -0.14010170102119446, -0.169158935546875, -0.02885737270116806, 0.021755650639533997, 0.04260515421628952, -0.043104566633701324, -0.025296520441770554, -0.17171531915664673, 0.16279539465904236, 0.13469788432121277, -0.09505301713943481, -0.03838266432285309, -0.08058729767799377, -0.04138176888227463, -0.0841444730758667, -0.19358119368553162, -0.051452331244945526, 0.04953712224960327, -1.0051351750917092e-07, 0.06135653704404831, -0.1438305675983429, 0.1089734435081482, -0.07549387216567993, 0.027148794382810593, -0.04912309721112251, -0.019001847133040428, 0.0743972435593605, 0.10070107877254486, 0.2390184998512268, 0.14284875988960266, 0.05925193428993225, -0.22203940153121948, -0.009339402429759502, -0.13195765018463135, 0.0895964726805687, -0.1398404836654663, 0.06771597266197205, 0.016700053587555885, -0.17096760869026184, -0.1138397827744484, 0.10390523076057434, 0.162000834941864, -0.12075231969356537, 0.1448981761932373, -0.06290582567453384, -0.11068825423717499, -0.04781077802181244, 0.020970342680811882, 0.11988379061222076, 0.04399574548006058, -0.026888960972428322, 0.1299973428249359, 0.045328523963689804, -0.05460622161626816, -0.06711223721504211, 0.10125654190778732, 0.038980741053819656, 0.019326094537973404, 0.006140674464404583, 0.09584298729896545, 0.06392645835876465, 0.008165013045072556, 0.02632155641913414, -0.0005465466529130936, -0.11899997293949127, -0.03846357390284538, 0.007703416980803013, 0.12696880102157593, -0.2021808624267578, 0.08055870980024338, -0.07562793046236038, 0.021114734932780266, -0.08674663305282593, -0.020498163998126984, -0.0256869625300169, -0.1919461488723755, -0.022852404043078423, -0.10394003242254257, -0.013309662230312824, 0.10687586665153503, -0.1727784126996994, 0.1297932267189026, 0.1446995735168457], "changes": {"1wk": 6.016846868258794}}, {"text": "LIVE The latest news and updates on Trump's tariffs Here\u2019s Why Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Is Among the Best Diabetes Stocks to Buy Under $10 Laiba Immad Mon, Jan 6, 2025, 4:45 PM 6 min read We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10 . In this article, we are going to take a look at where Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) stands against the other diabetes stocks. Global Growth and Innovation in Diabetes Care: The Rise of Continuous Glucose Monitors and AI Integration About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average. Both the number of cases and the prevalence of diabetes have steadily increased during the last several decades. However, according to the International Diabetes Federation, there are currently 500 million people with diabetes globally, and that number is expected to rise by 25% by 2030 and 51% by 2045. The continuous glucose monitor (CGM) is one type of medical equipment used to help manage diabetes, including type 1 and type 2. It is now a rapidly growing segment of diabetic care devices, and the market has increased significantly in recent years. According to GlobalData, the demand for sophisticated diabetes care products, such as insulin pumps, pens, and continuous glucose monitoring (CGM) devices, was projected to be valued at $21.8 billion in 2023. According to GlobalData's forecasts, the market will grow at a compound annual growth rate (CAGR) of 6.34% to reach revenues of $33.4 billion by 2030. There are now 97 goods in the CGM category, according to the GlobalData marketed products database. Only a small number of these devices are implantable sensors; the majority are conventional CGMs. The GlobalData pipeline products database indicates that 133 goods are either approved or in the development stage. According to the data, this market niche is growing rapidly and is a center for cutting-edge new technologies such as implantable CGMs. AI is now being included in CGM technology. For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien Boisdron described it as \u201ca solution more than a CGM\u201d at the introduction. He explained how the system, which includes a sensor and two algorithms, helps with prediction and data visualization. Rising Demand for GLP-1 Medications: Opportunities and Challenges in Diabetes and Obesity Treatment The management of diabetes and its related complications has entered a new era of opportunity. The combined issues of diabetes and obesity can be effectively treated with these innovative approaches. Glucagon-like peptide-1 (GLP-1) agonists are a class of medications used to treat type 2 diabetes mellitus (T2DM) and obesity. The GLP-1 market, which is driven equally by diabetes and obesity, is predicted to reach $100 billion by 2030. By this time, there could be 30 million GLP-1 users or around 9% of the US population. Story Continues According to the most recent KFF Health Tracking survey, 12% of adult Americans say they have used a GLP-1 medication at some point. In the past five years, 43% of GLP-1 prescription users had diabetes, and 22% of patients with obesity or overweight diagnoses also took the medication. Over the course of the past year, the percentage of adults who have heard \"a little\" or \"a lot\" about these medicines has climbed from 70% to 82%, while the percentage of adults who have heard \"a lot\" or \"a lot\" about them has increased from 19% to 32%. However, the rising demand for these weight-loss and diabetes drugs has created challenges. The National Pharmacy Association (NPA) warned of a possible \"explosion in the unlicensed sale of medication online.\" Semaglutides, marketed under the name Ozempic, assist people with type 2 diabetes in controlling their blood sugar levels. However, they are also frequently used to aid in weight loss in certain nations, such as the US, where they are marketed under the name Wegovy. NPA chairman Nick Kaye stated: \u201cPharmacists remain deeply concerned that the current medicine shortages crisis could lead to an explosion in the unlicensed sale of medication online.\u201d Our Methodology Our methodology involved identifying healthcare companies focused on diabetes treatment using a stock screener. From the resultant dataset, we selected those with stock prices under $10 and ranked them based on their share price as of the close of December 26. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ( see more details here ). A pharmaceutical laboratory filled with shelves of medicines, highlighting the company's specialty drug production. Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX ) Share Price as of the Close of December 26: $7.85 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) develops and distributes affordable generic and specialty drugs, including key diabetes treatments. Its products include generic metformin, a first-line medication for type 2 diabetes, and recently FDA-approved exenatide, a GLP-1 agonist for managing type 2 diabetes. The company\u2019s focus on complex generics enables cost-effective, advanced treatment options. Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) reported strong Q3 2024 results with net revenue of $702 million, a 13% increase from the previous year. Generics revenue grew by 9%, while specialty revenue rose 19%, driven by products in neurology and endocrinology. Adjusted EBITDA was $158 million, up 2%, and adjusted EPS was $0.165. Year-to-date, the company generated $2.68 billion in revenue, driven by strong generics performance, new product launches, and biosimilars. Despite a small GAAP net loss of $0.2 million, the company is focused on high-margin products to improve profitability. Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) has partnered with Metsera, Inc. to develop next-generation treatments for obesity and metabolic diseases, leveraging its network and facilities to support Metsera's injectable and oral programs, including GLP-1 and amylin receptor agonists. The company has also resubmitted its New Drug Application for the DHE Autoinjector, plans to launch CREXONT for Parkinson's disease, and acquired a high-value biosimilar to strengthen its market position. These initiatives, alongside its focus on complex generics and specialty pharmaceuticals, highlight Amneal's commitment to growth and innovation in the pharmaceutical industry. Analysts hold a consensus Strong Buy rating on Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), making it one of the best diabetes stocks to watch. As of Q3 2024, 16 hedge funds held shares in the stock, as tracked by the Insider Monkey database. The largest stakeholder in the company was Rubric Capital Management with stakes worth $89.2 million. Overall AMRX ranks 10th on our list of the best diabetes stocks to buy under $10. While we acknowledge the potential of AMRX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than AMRX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock Disclosure: None. This article is originally published at Insider Monkey . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "AMRX", "date": "2025-01-06T16:45:18", "sentiment": {"score": 0.24394019041210413, "confidence": 0.25429028272628784, "probabilities": {"positive": 0.25429028272628784, "negative": 0.010350092314183712, "neutral": 0.7353596687316895}}, "embedding": [-0.06888049095869064, -0.05078023299574852, -0.04870738461613655, 0.017437385395169258, -0.0021772761829197407, -0.02609172835946083, 0.07097324728965759, 0.19905731081962585, 0.059105098247528076, 0.09167271852493286, -0.170724019408226, 0.08298639208078384, -0.0469440259039402, 0.08945630490779877, -0.12034598737955093, -0.02100864239037037, 0.04672267287969589, -0.07137896120548248, -0.02526567131280899, 0.05530974268913269, 0.05376191809773445, 0.0009071873500943184, 0.13234388828277588, 0.052135713398456573, -0.1117052435874939, -0.04611365497112274, -0.03763457387685776, -0.151628315448761, -0.06983973830938339, -0.00011243671178817749, -0.09047619998455048, 0.06447455286979675, 0.07230626046657562, 0.013674999587237835, -0.09609796106815338, 0.08602386713027954, -0.047071442008018494, -0.08158260583877563, -0.128611221909523, -0.13105462491512299, 0.09678622335195541, -0.1123732477426529, -0.07968289405107498, 0.020659534260630608, 0.08196055889129639, -0.09340205788612366, -0.06978947669267654, 0.049639992415905, 0.040615472942590714, 0.15532198548316956, -0.13975954055786133, -0.05931735783815384, 0.07891401648521423, 0.02132735773921013, 0.04267701879143715, -0.016327859833836555, -0.1445126235485077, -0.08934654295444489, 0.04780134558677673, -0.0112691018730402, -0.022897446528077126, 0.004624064080417156, 0.04486902803182602, 0.009240709245204926, 0.008047465234994888, 0.005583140067756176, -0.07630869001150131, 0.007366280071437359, -0.005324870347976685, -0.044717900454998016, -0.050592727959156036, -0.09556101262569427, 0.05056772008538246, 0.03794671595096588, -0.0051190974190831184, 0.03763769567012787, 0.13296417891979218, 0.005519519560039043, 0.13429832458496094, 0.01566912978887558, 0.06755975633859634, 0.01049649715423584, 0.15100078284740448, -0.027720658108592033, 0.043325163424015045, -0.018262766301631927, 0.10280457139015198, 0.07723978161811829, 0.03174920380115509, -0.1268804371356964, -0.00956437736749649, 0.059254370629787445, -0.12257873266935349, 0.031256407499313354, -0.056031741201877594, -0.06094622611999512, -0.03490247577428818, -0.015859901905059814, 0.04786311835050583, 0.013410755433142185, 0.05400567129254341, 0.023985056206583977, 0.07446058839559555, 0.0019118478521704674, -0.14609000086784363, -0.10146115720272064, 0.0034602992236614227, 0.010739264078438282, 0.1306268572807312, 0.142390176653862, -0.13439521193504333, 0.08486199378967285, -0.05658581852912903, -0.07865297794342041, -0.11873813718557358, 0.11920575797557831, -0.07750625908374786, -0.06624504923820496, 0.1775384098291397, 0.1550954282283783, -0.05454375222325325, -0.06696751713752747, 0.004978278651833534, -0.10838861763477325, 0.08077917993068695, 0.1994870901107788, -0.006234065629541874, 7.951005585395551e-33, -0.08534562587738037, -0.0062883831560611725, 0.01657288707792759, -0.08408043533563614, -0.10179972648620605, 0.12351686507463455, 0.055013734847307205, 0.12778300046920776, 0.018996253609657288, -0.08808039873838425, -0.2261032611131668, 0.10226347297430038, -0.059899553656578064, 0.17083147168159485, 0.1097373217344284, -0.17828702926635742, 0.06763483583927155, -0.011734403669834137, 0.07545538991689682, -0.022404015064239502, -0.07720109820365906, 0.0029006972908973694, 0.0880717784166336, 0.06642430275678635, 0.0860595703125, 0.037872351706027985, -0.036761581897735596, 0.11321109533309937, 0.0647311806678772, 0.032621439546346664, 0.03704456984996796, 0.10234156250953674, 0.07764764130115509, -0.11265742778778076, -0.039702482521533966, -0.03824012354016304, -0.07282434403896332, 0.013073105365037918, -0.01586080715060234, -0.00947873666882515, -0.006444751285016537, 0.1390627920627594, 0.05617649108171463, -0.150133416056633, 0.032324351370334625, 0.02644464559853077, -0.01149034034460783, -0.010368915274739265, -0.008750613778829575, -0.04058012366294861, -0.12430043518543243, 0.06681147962808609, -0.06319023668766022, -0.031386565417051315, 0.09586992859840393, -0.0014842776581645012, -0.12049578130245209, -0.14141759276390076, 0.07620061188936234, 0.11663982272148132, -0.1497993767261505, 0.09456926584243774, -0.01065191999077797, 0.054644301533699036, -0.05693657696247101, 0.13393191993236542, -0.005960968788713217, 0.0632954016327858, -0.10775241255760193, 0.05940526723861694, 0.0392000786960125, -0.04883188754320145, 0.02104933187365532, -0.06055250018835068, -0.018365029245615005, 0.048970818519592285, -0.009018399752676487, -0.014514964073896408, -0.039693258702754974, -0.05091702193021774, 0.03267927095293999, 0.057909004390239716, 0.030227739363908768, 0.03380516543984413, 0.036349475383758545, 0.019974621012806892, -0.05961848795413971, 0.037602514028549194, -0.07174459099769592, -0.1108739823102951, -0.06973510980606079, 0.07017817348241806, -0.01476204488426447, 0.0626741424202919, -0.08029818534851074, -1.1263054958385412e-32, -0.03837493807077408, 0.055511847138404846, 0.033040426671504974, -0.01156539935618639, 0.048825494945049286, -0.03798648342490196, 0.13558731973171234, -0.231617271900177, 0.08387159556150436, -0.02680979296565056, -0.008841153234243393, 0.0709938183426857, 0.06361854076385498, 0.14923478662967682, -0.05269898474216461, 0.08971607685089111, -0.1599472463130951, -0.059433672577142715, -0.08853873610496521, -0.050506606698036194, 0.024395806714892387, 0.1988496482372284, -0.12821881473064423, 0.02912864461541176, -0.09255173802375793, 0.07981391251087189, -0.04589002579450607, 0.10527066886425018, 0.03151339292526245, -0.08499743044376373, -0.0929775983095169, -0.02775951847434044, -0.12418290972709656, 0.08449692279100418, -0.0020581530407071114, -0.07829025387763977, -0.061041660606861115, -0.08043526113033295, 0.023885561153292656, -0.06760499626398087, 0.236805260181427, 0.08973348885774612, -0.02886398695409298, -0.09073039144277573, 0.0868135541677475, -0.050964564085006714, -0.011309726163744926, -0.011520370841026306, 0.0578453354537487, -0.07890095561742783, -0.1671428084373474, -0.011066623032093048, -0.0424242839217186, -0.04131244868040085, -0.18561609089374542, 0.033552780747413635, -0.0027009560726583004, -0.002970482688397169, -0.09568104147911072, -0.03926558792591095, 0.0680985152721405, 0.014799038879573345, 0.06201741471886635, 0.033219289034605026, 0.07008294016122818, -0.00044465530663728714, 0.2620213031768799, -0.08495675772428513, 0.08286695182323456, -0.07098756730556488, 0.032187286764383316, -0.017078712582588196, -0.01367541030049324, -0.08531596511602402, -0.07163484394550323, 0.049800291657447815, -0.0632324069738388, -0.05676617473363876, -0.06275439262390137, -0.10230714082717896, 0.08910776674747467, -0.06887152791023254, 0.07441980391740799, -0.07436724007129669, -0.034281425178050995, -0.0007020259508863091, 0.02193097397685051, -0.15102781355381012, -0.005712450481951237, 0.09576290845870972, -0.16974246501922607, 0.019915569573640823, -0.13876250386238098, -0.04168042540550232, 0.038048382848501205, -1.008725547535505e-07, 0.1226247251033783, 0.007365664467215538, 0.05239439010620117, 0.020983435213565826, 0.02015697956085205, -0.0824316218495369, -0.04390488937497139, 0.0701017677783966, 0.0719766914844513, 0.13538044691085815, 0.07013988494873047, 0.1514706313610077, -0.08735254406929016, -0.025460774078965187, -0.03557828068733215, 0.029942383989691734, -0.11056143045425415, 0.09704416990280151, -0.03181732818484306, 0.009139157831668854, -0.12850554287433624, 0.05667538940906525, -0.019423317164182663, -0.014898336492478848, 0.039016902446746826, -0.10203631222248077, -0.012101825326681137, 0.013210182078182697, -0.022613631561398506, 0.025507763028144836, -0.0002002750989049673, 0.0031231511384248734, 0.26246631145477295, 0.10029889643192291, 0.004933193325996399, -0.11934705078601837, 0.06657643616199493, 0.06289992481470108, -0.04672190546989441, 0.017969511449337006, 0.0643957257270813, -0.056069470942020416, -0.058985017240047455, -0.025118369609117508, -0.05759868025779724, -0.13072457909584045, -0.03183283656835556, -0.05280214548110962, 0.023309728130698204, 0.07825864851474762, -0.053902722895145416, -0.019135406240820885, -0.03929439187049866, -0.07299395650625229, 0.103392094373703, -0.06397592276334763, -0.2184053510427475, -0.04049236699938774, -0.06955620646476746, 0.023774592205882072, 0.04010000452399254, -0.2315647006034851, 0.0858118012547493, 0.014299361035227776], "changes": {"1wk": 2.5740001255609815}}]